Details about the neuroanatomical projections from ORBvl to ECT
To view more data and metadata associated with each report, click on its ID.
| Report ID | Sending structure | Receiving structure | Projection strength | Technique | General description projection | Collator | Associated reference |
|---|---|---|---|---|---|---|---|
| 91796 | Orbital area ventrolateral part | Ectorhinal area | moderate | biotinylated dextran amine (BDA) | this injection gave rise to a dense plexus of labeled terminal axons rostrally in PER at the fundus and the dorsal bank of the rhinal sulcus, involving dorsal area 35 and ventral area 36 (Figs. 5B, 11B). This patch of dense axonal label was located in a restricted rostrocaudal zone (less than 1 mm), where the dorsal hippocampus makes contact with the ventral hippocampus in coronal sections. Collator note: the label in ECT is moderate, and in layers I-III. See Fig 5B, Swanson Atlas Levels 32-33. | Kondo H. & Witter M.P., 2014 | |
| 91798 | Orbital area ventrolateral part | Ectorhinal area | moderate/strong | biotinylated dextran amine (BDA) | Collator note: rostralmost, PERI is labeled strongly-moderate, in layers II-V. See Fig. 5A, Swanson Atlas Level 31. | Kondo H. & Witter M.P., 2014 | |
| 91801 | Orbital area ventrolateral part | Ectorhinal area | moderate/strong | biotinylated dextran amine (BDA) | Labeling intensity in PER decreased at more caudal levels (Fig. 5C,D) […]. Collator note: terminals making a distinct fieId in layer III. See Fig. 5C, Swanson Atlas Levels 33-34. | Kondo H. & Witter M.P., 2014 | |
| 91802 | Orbital area ventrolateral part | Ectorhinal area | moderate/strong | biotinylated dextran amine (BDA) | Collator note: distinct terminal field in layer III of the ECT. See Fig. 5C, Swanson Atlas Levels 33-34. | Kondo H. & Witter M.P., 2014 | |
| 91803 | Orbital area ventrolateral part | Ectorhinal area | moderate | biotinylated dextran amine (BDA) | Collator note: at least moderate labeling in the caudal ECT, mostly in layer III. See Fig. 5E, Swanson Atlas Levels 45-46. | Kondo H. & Witter M.P., 2014 | |
| 91805 | Orbital area ventrolateral part | Ectorhinal area | strong | biotinylated dextran amine (BDA) | […] dense labeling in POR, particularly in the superficial layers at more caudal levels (Figs. 5F, 12A). Collator note: dense labeling in the caudalmost part of both ECT and TEA, in layers II-III. See Fig. 5F, Swanson Atlas Levels 46-47. | Kondo H. & Witter M.P., 2014 | |
| 91820 | Orbital area ventrolateral part | Ectorhinal area | moderate/strong | biotinylated dextran amine (BDA) | Caudal POR showed moderate to dense labeling of terminating axons (Figs. 6F, 12B), was also the case for the rostral PER, especially around the border between areas 35 and 36 (Fig. 6B). Collator note: moderate-strong terminal field in the dorsal PERI and ventral ECT, in layers II-III. Se Fig. 6B, Swanson Atlas Levels 32-33. | Kondo H. & Witter M.P., 2014 | |
| 91822 | Orbital area ventrolateral part | Ectorhinal area | very light | biotinylated dextran amine (BDA) | Labeling in PER decreased at more rostral levels (Fig. 6A) and at more caudal levels (Fig. 6C,D). Collator note: very few labeled fibers in the rostralmost part of the PERI and ECT. See Fig. 6A, Swanson Atlas Levels 30-31. | Kondo H. & Witter M.P., 2014 | |
| 91824 | Orbital area ventrolateral part | Ectorhinal area | moderate | biotinylated dextran amine (BDA) | Collator note: terminal field in layers III and V, in ECT, caudalmost. See Fig. 6E, Swanson Atlas Levels 45-46. | Kondo H. & Witter M.P., 2014 | |
| 91825 | Orbital area ventrolateral part | Ectorhinal area | moderate/strong | biotinylated dextran amine (BDA) | Collator note: quite strong terminal field in the caudalmost ECT, layers II-V. See Fig. 6F, Swanson Atlas Levels 46-48. | Kondo H. & Witter M.P., 2014 |
| General description technique/protocol: In a representative case (case F-17), the BDA injection targeted the lateral portion of VO at a caudal level (Figs. 2, 5). The injection involved mainly layers II and III.Collator note: injection in the caudal third of the ORBvl. See Figs. 1, 2, and 5. The injection is mapped here onto Swanson Atlas Levels 5-6. |
Further details associated to record number 91824:
|
|
|---|
